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Abstract
Objective—To test whether the association between depressive symptoms and cardiovascular
disease (CVD) mortality is stronger among blacks than whites. Design, Setting and Participants:
2,638 black and 15,132 white participants from a prospective, observational study of community-
dwelling Health and Retirement Study participants (a nationally representative sample of U.S.
adults age 50+). Average follow-up was 9.2 years. Outcome Measure: Cause of death (per ICD
codes) and month of death were identified from National Death Index linkages.
Methods—The associations between elevated depressive symptoms and mortality from stroke,
ischemic heart disease (IHD), or total CVD were assessed using Cox proportional hazards models
to estimate adjusted hazard ratios (HRs). We used interaction terms for race by depressive
symptoms to assess effect modification (multiplicative scale).
Results—For both whites and blacks, depressive symptoms were associated with a significantly
elevated hazard of total CVD mortality (whites: HR=1.46; 95% CI: 1.33, 1.61; blacks: HR=1.42,
95% CI: 1.10, 1.83). Adjusting for health and socioeconomic covariates, whites with elevated
depressive symptoms had a 13% excess hazard of CVD mortality (HR=1.13, 95% CI: 1.03, 1.25)
compared to whites without elevated depressive symptoms. The HR in blacks was similar,
although the confidence interval included the null (HR=1.12, 95% CI: 0.86, 1.46). The hazard
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associated with elevated depressive symptoms did not differ significantly by race (p>0.15 for all
comparisons). Patterns were similar in analyses restricted to respondents age 65+.
Conclusions—Clinicians should consider the depressive state of either black or white patients
as a potential CVD mortality risk factor.
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depression; stroke; cardiovascular disease; mortality; race
Introduction
Racial disparities in cardiovascular disease among U.S. adults are well established: blacks
have a higher risk of both cardiovascular disease (CVD) incidence and mortality than
whites.1 The association between psychosocial factors such as depression and cardiovascular
disease is also well documented.2-5 For example, meta-analyses suggest depression is
associated with a 69% elevated relative risk of coronary heart disease (CHD) mortality6, a
55% elevated relative risk of fatal CVD,3 and a between a 35%7 and 50% elevated odds of
fatal stroke.8 However, racial differences in the association between depression and CVD
mortality are not well understood. Because racial differences in CVD attenuate with age, it
is important to compare how race may modify the association between depressive symptoms
and CVD mortality risk from middle to older age.
As Everson-Rose and Lewis suggested in their review of the literature on this issue, few
prior studies have sufficient representation of blacks to adequately examine this question.9
The few available studies on racial differences in the association between depression and
CVD report mixed results. A recent study by Lewis et al.10 stands out because of the diverse
participant sample providing an opportunity to address this question. They found that
depressive symptoms were associated with elevated odds of CVD mortality for blacks but
not whites. However, this finding contrasts with some prior work showing associations
between depressive symptoms and stroke incidence in both blacks and whites.11-13 These
new results are also somewhat inconsistent with several earlier studies that reported
associations between depressive symptoms and CVD mortality in predominantly white
general population samples.14,15
Our study assessed differences in CVD mortality associated with elevated depressive
symptoms using a large cohort of U.S. black and white adults aged 50+. We hypothesized
that depressive symptoms would predict CVD mortality in blacks and whites, with no
significant variation in the magnitude of association by race. We also assessed whether this
association varied by age.
Methods
Study Population
The Health and Retirement Study (HRS) is a nationally-representative longitudinal survey of
U.S. adults aged 50+ years and their spouses. Details of the study are provided
elsewhere.16,17 Enrollments occurred in 1992, 1993, 1998 (based on respondent’s birth year)
with assessments occurring approximately every two years. However, in order to have a
consistent measure of depressive measures the following years were considered baselines:
1996, 1995, and 1998, respectively. The 2004 and subsequent HRS enrollees were not
included in this analysis. We followed participants from baseline through the 2008 wave
mortality assessment; retention rates through 2008 were above 80%. HRS was approved by
the University of Michigan Health Sciences Human Subjects Committee and these analyses
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were approved by the Harvard School of Public Health Office of Human Research
Administration.
Of the full HRS sample enrolled in 1992, 1993 or 1998 (n=27,473), we excluded 8,536 who
were age ineligibe or with a sampling weight of 0 (31.1%); 1,386 (5.1%) who were
Hispanic; 1,284 (4.7%) missing exposure assessment; and 426 (1.6%) who were missing key
covariate information to ensure complete case analysis; leaving 15,845 respondents for the
analyses.
Assessment of Depressive Symptoms
We defined elevated depressive symptoms based on the baseline measure of a modified, 8-
item version of the Centers for Epidemiologic Studies-Depression (CES-D) scale. Our
outcome variable, hereafter called “elevated depressive symptoms,” was a dichotomized
indicator of whether the respondent reported experiencing 3 or more of the following
symptoms in the last week: feeling depressed, feeling everything was an effort, restless
sleep, feeling happy (reverse coded), feeling lonely, enjoying life (reverse coded), feeling
sad, and could not get going. The 3+ cutpoint was based on prior psychometric validation
studies.18,19
Assessment of Mortality
HRS respondents’ deaths were confirmed via linkage to the National Death Index conducted
in May, 2009. For deaths prior to 1999, cause of death was characterized using the
International Classification of Diseases, Ninth Revision (ICD-9). Total CVD deaths
included ICD codes 390 to 459; strokes included 430 to 438 and IHD included 410 to 414.
For deaths after 1999, cause of death was characterized using the International Classification
of Diseases, Tenth Revision (ICD-10). Total CVD deaths were classified as those with
ICD-10 codes I00-99.9; strokes comprised I60-I69 and IHD comprised I20-I25.
Covariates
We considered groups of demographic covariates and health risk factors as potential
confounders. All covariates were self-reported. We used the earliest reported values for each
covariate. Demographics included race (black/white), age (continuous), and sex (male/
female). Socioeconomic status was measured as years of education (0-17). The health risk
factors included body mass index (BMI) as a categorical variable (<18.5; 18.5-24.9,
reference; 25-29.9; ≥30); smoking status (current and ever, never as reference); physical
activity, measured as an indicator variable of regular (1+ times per week) physical activity in
the previous two weeks (yes/no); a summary score of self-reported history of a doctor’s
diagnosis of chronic conditions (high blood pressure, diabetes, cancer, lung disease, and
arthritis; range 0-5), consistent with prior literature10; heart medication usage (“Are you now
taking or carrying medication for your heart problem?”, yes/no); and psychiatric medication
usage (“Do you now take tranquilizers, antidepressants, or pills for nerves?”, yes/no).
Methods of Statistical Analysis
The hazard of CVD mortality associated with elevated depressive symptoms was assessed
using age- and sex-adjusted Cox proportional hazard models stratified by race. Two
additional models included covariates to adjust for CVD risk factors: first, socioeconomic
and health status variables (education, comorbidity summary score, body mass index) and
then health behaviors (smoking, physical activity). These factors likely partially mediate the
causal pathway, so the results may understate the full causal effect of disease. Person-time
was calculated from the initial interview date until the date of their death. These estimates
were calculated using PROC PHREG in SAS version 9.3 (SAS Institute, Inc., Cary, NC),
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with the sampling weight from the first interview applied. We tested for effect modification
on a multiplicative scale by examining the interaction between race and elevated depressive
symptoms. Sensitivity analyses included the same models estimated in a sample restricted to
respondents age 65+ at baseline (n=8,680). HRS has a complex survey design; however,
based on prior work suggesting minimal design effects, we treated the data as a simple
random sample in these analyses (design effect estimates available from authors).
Results
There were 13,444 white and 2,401 black respondents in this analysis. There was an average
of 9.2 years of follow-up in the total sample and 8.4 among those age 65+ at enrollment. The
mean age of our cohort was similar for blacks (65.3, SD=10.0) and whites (67.1, SD=10.3)
(Table 1). Prevalence of elevated depressive symptoms was higher in blacks (27.6%) than
whites (18.1%). Whites had more years of education and generally better heath than blacks:
whites had lower BMI, lower prevalence of current smoking, higher prevalence of physical
activity, and higher prevalence of heart medication usage than blacks. Blacks and whites had
similar prevalence of chronic diseases and psychiatric medications (Table 1).
In the total sample, elevated depressive symptoms were associated with a significant
elevation in hazard of total CVD mortality after adjusting for sex and age in both blacks
(HR=1.42, 95% CI: 1.10, 1.83) and whites (HR=1.46, 95% CI: 1.33, 1.61) (Table 2). The
estimated associations for IHD and stroke outcomes were similar between whites and
blacks. The estimated association did not vary significantly by race for total CVD (p=0.76
for test of interaction), IHD (p=0.97) or stroke mortality (p=0.76).
Results were similar in analyses restricted to respondents age 65+ at baseline (Table 2,
bottom panel). For example, restricting to those age 65+, elevated depressive symptoms
were associated with a 37% excess hazard of total CVD mortality (HR=1.37, 95% CI: 1.02,
1.85) among blacks and 38% excess hazard among whites (HR=1.38, 95% CI: 1.25, 1.53).
Among those aged 65+, the estimated associations between elevated depressive symptoms
and IHD and stroke mortality were similar to those for the total sample aged 50+ for both
blacks and whites, although the association for strokes among blacks had a wide confidence
interval that crossed the null (HR=1.24, 95% CI: 0.54, 2.85). Like those aged 50+, the
hazard of mortality associated with depressive symptoms did not vary significantly by race
among those aged 65+ for total CVD (p=0.99), IHD (p=0.91) or stroke mortality (p=0.72).
After adjusting for demographics and potential CVD risk factors, the estimated association
between depressive symptoms with total CVD mortality was attenuated: whites with
depressive symptoms had a 23% elevation in hazard of CVD mortality (HR=1.23, 95% CI:
1.11, 1.35); and blacks with depressive symptoms had an 18% elevation (HR=1.18, 95% CI:
0.91, 1.54) with a confidence interval that included the null. The associations for other
outcomes and among those 65+ were also attenuated; among blacks, adjustment for
covariates led to wider confidence intervals that crossed the null (Table 2, Model 2).
Models were then adjusted for health behaviors (smoking and physical activity), which
further attenuated the associations. For example, the estimated association between
depressive symptoms and total CVD mortality was a 12% increased hazard of mortality for
blacks (HR=1.12, 95% CI: 0.86, 1.46) and 13% increased hazard for whites (HR=1.13, 95%
CI: 1.03, 1.25) (Table 2, Model 3). The association between depressive symptoms and CVD
mortality did not vary significantly by race in this adjusted model (p=0.56 for test of
interaction of total sample; for 65+, p=0.58). There were similar patterns of attenuation for
the IHD and stroke; and for all outcomes among those aged 65+. Results were almost
identical when controlling for use of psychiatric and heart medications (results not shown).
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Models stratified by follow-up time suggested the associations attenuated very little with
longer duration of follow-up; for example in pooled analyses the HR for years 0-8 was 1.55
(95% CI: 1.38-1.73), while for years 9-15, the association was 1.47 (95% CI: 1.16, 1.87).
Discussion
This study found that elevated depressive symptoms were associated with an increased
hazard of CVD mortality among blacks and whites after statistically controlling for age and
sex. The magnitude of the age- and sex-adjusted relative association between elevated
depressive symptoms and CVD mortality was similar for blacks (total sample: HR=1.42,
65+: HR=1.37) and whites (total sample: HR=1.46, 65+: HR=1.38) and there was no
significant difference by race in the hazard associated with higher depressive symptoms for
total CVD mortality, stroke mortality, or IHD mortality. The age and sex-adjusted HR point
estimates indicated blacks had similar magnitudes of association between depression and
both stroke and IHD mortality compared to whites. None of the differences were statistically
significant. Patterns differed little when considering the population age 50+ compared to age
65+.
Adjustment for additional covariates attenuated the associations for all outcomes and
groups. The associations remained statistically significant in whites after adjustment for
socioeconomic, health status, and health behavior variables. Although the point estimates in
the models were similar for blacks and whites, the CIs for blacks were wider and included
the null. However, the health covariates and health behaviors included in these models likely
partially mediate the association between depression and CVD outcomes. Adjusting for such
mediators likely underestimates the causal effect of depressive symptoms on CVD mortality.
Study Limitations and Strengths
Although using a brief symptom scale (CES-D) rather than diagnosis of clinical depression
is a potential limitation of this study, our measure is very similar to that used by prior
studies.10 Furthermore, our cut-point for elevated depressive symptoms has also been shown
to have high sensitivity and specificity for clinical depression.19
We controlled for particular health variables to facilitate comparisons with prior
literature;6,10 however, we recognize that without better knowledge of the temporal order of
covariates these models may yield biased results because of mediation. Although controlling
for psychiatric medication use did not change our findings, this result should be interpreted
cautiously because the measure available in HRS was limited.
The wide confidence intervals of estimates for blacks reflect low sample size in this stratum;
this is particularly true for IHD and stroke otucomes as well as in multivariable adjusted
models. We may be underpowered to detect a result for this group. However, the interaction
term test indicated no significant difference in effect sizes for blacks and whites. We
examined interactions by race on a multiplicative rather than additive scale because the Cox
model is naturally multiplicative. Our results support the use of a multiplicative model in
that we found no evidence for deviation from multiplicativity in our interaction tests.
However, because CVD mortality is generally higher among younger blacks than whites, the
absolute excess event rate induced by depressive symptoms may be larger among blacks,
even if the relative effects are the same.
This study has a number of important strengths. The cause of death was linked from the
National Death Index. Secondly, we used identical analytic design, measures, and analyses
to prior research in this area, which improves the comparability of our findings to the extant
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literature. Lastly, we use a nationally-representative sample, enhancing the generalizability
of findings.
Comparisons to prior literature
These results are consistent with prior literature that suggests depressive symptoms are
associated with increased CVD-related mortality and incidence.5,6,11,20-23 Furthermore, our
results are of a similar magnitude to those found in prior studies.24 Our estimates are lower
than results from meta-analyses3,6,7,25 of the association between depression and incident
cardiovascular events; however, differences in the study designs, age of the population,
control variables, and exposure and outcome variables may account for these differences. As
van der Kooy and colleagues3 note in their meta-analysis of this association among the
elderly, depressive symptoms do not predict CVD onset as strongly as clinical diagnosis of
depression.
We do not find differences in this association by race among either those aged 50+ or among
the older age cohort, which contributes to a somewhat mixed literature on the racial
differences in the association between depression and CVD. Some studies report no racial
difference in the association between depression and stroke onset11,13. However, our results
contrast with recent findings by Lewis et al10 who found that the effects of depressive
symptoms on cardiovascular mortality among those aged 65+ varied significantly by race in
the Chicago Health and Aging Project (CHAP) cohort. For example, they found depressive
symptoms were associated with a more modest and non-significant elevation in age- and
sex-adjusted hazard of CVD mortality among whites in CHAP (HR=1.26; 95% CI: 0.95,
1.68) than we find in HRS (HR=1.38; 95% CI: 1.25, 1.53), but a higher elevation among
blacks in CHAP (HR=1.95; 95% CI: 1.61, 2.36) than HRS (HR=1.37; 95% CI: 1.02, 1.85).
The divergence in these hazard ratios may reflect distinct features of a geographically
defined, urban cohort, such as shared life experiences or exposure to other contextual or
environmental risk factors26 that exacerbated the hazard of CVD mortality associated with
depression that would not be present in a nationally representative sample. Consistent with
this possibility, chronic life stress was associated with carotid intima-media thickness in
blacks but not whites in the Pittsburgh site of the Study of Women’s Health across the
Nation (SWAN).27 In the Midlife in the United States (MIDUS) study, which is enriched
with African Americans from Milwaukee, early life adversity was associated with elevated
inflammatory markers among blacks but not whites;28 the authors suggest that racial
interactions may be most evident in populations drawn from high-poverty urban areas.
Implications and Conclusions
Clinicians should be aware of the elevated hazard for cardiovascular mortality associated
with depressive symptoms, regardless of a patient’s race. However, there are important
racial differences in prevalence and treatment of depressive symptoms: in this sample,
although blacks had almost 10% higher prevalence of depressive symptoms than whites,
blacks and whites reported similar rates of psychiatric medication usage. A critical,
unanswered question remains regarding whether CVD mortality risk declines when
depressive symptoms resolve or are successfully treated. Further studies of this association
are needed in samples adequately powered to test differences between whites and non-white
samples to replicate the results of a limited number of studies. In addition, future studies
should explicitly assess differences in this association by race to see how the risk of
mortality changes into older age.
In sum, our results indicate depressive symptoms increased the hazard of cardiovascular
mortality for whites and blacks, and the effect does not vary significantly by race. The
patterns were similar among those in middle age (50+) and those in older age (65+).
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Table I
Baseline Participant Characteristics of Total Sample and by Race












Average years of follow-up 9.1±3.7 9.0±3.7 9.1±3.7 8.1±3.9 7.9±3.9 8.1±3.9
Age 66.8±10.3 65.3±10.0 67.1±10.3 76.3±6.3 76.4±6.5 76.3±6.2
Male, % 42.3 36.2 43.4 38.9 33.9 39.6
Education 12.2±3.0 10.7±3.6 12.5±2.8 11.7±3.3 9.2±4.0 12.0±3.0
Depressive Symptoms ≥3, % 19.6 27.6 18.1 21.2 28.2 20.3
BMI 26.8±5.1 28.6±5.9 26.4±4.9 25.8±4.7 27.4±5.4 25.6±4.5
BMI 4 categories, %
 BMI <18.5 2.1 1.6 2.2 3.2 2.3 3.3
 18.5≤BMI<25 36.4 24.7 38.4 42.7 31.6 44.3
 25≤BMI<30 39.8 40.2 39.7 38.2 40.1 38.0
 BMI≥30 21.7 33.5 19.6 15.9 26.0 14.5
Smoking Status, %
 Never-smoker 38.1 38.6 38.0 40.2 42.3 39.9
 Ever-smoker 41.9 36.5 42.9 45.0 38.3 46.0
 Current smoker 16.8 21.3 16.0 10.2 14.1 9.7
Chronic conditions,
median±IQR 1±2 1±1 1±2 1±1 2±1 1±1
Physically Active, % 45.0 37.4 46.4 37.5 26.7 39.0
Heart Medications, % 13.7 11.3 14.1 20.2 16.3 20.7
Psychiatric Medications, % 5.6 5.4 5.7 5.0 5.1 5.0
Note: BMI indicates body mass index, or kg/m2. Values are mean ± SD, median ± inter-quartile range, or percentage.
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Table II
Adjusted Hazard Ratios (95% Confidence Intervals) for Associations Between High Depressive Symptoms
and Types of Cardiovascular Mortality for Blacks and Whites
Blacks Whites
Events
Model 1 Model 2 Model 3
Events
Model 1 Model 2 Model 3
HR HR HR HR HR HR






































0.54, 2.85 0.52, 2.88 0.53, 2.96 1.25, 1.99 1.12, 1.81 1.04, 1.68
Notes: HR indicates Hazard Ratio, CI indicates Confidence Interval
Model 1 adjusts for demographics: age and sex. Model 2 adjusts for demographics and CVD risk factors: education, summary score of chronic
conditions, and body mass index. Model 3 adjusts for demographics, CVD risk factors, and health behaviors: smoking and physical activity.
p-values for race*depression interactions are p>0.05 for each outcome, in the full sample and of those age ≥ 65
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